AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇼

MOXIFLOXACIN HYDROCHLORIDE in Zimbabwe

9 products registered with MCAZ 9 active

Brand / ProductReg. No.HolderStatusExpires
FLOXSAFE 400
TABLET, COATED; ORAL
2025/7.3/7233PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactive23 Nov 2030
OXIFLED 400
TABLET, COATED; ORAL
2015/7.13/5113MSN LABORATORIES LTDactive16 Sept 2029
MOXIFLOXACIN
TABLET; ORAL
2015/7.3/5134MYLAN LABORATORIES LIMITEDactive28 Feb 2029
VIGAMOX
SUSPENSION/DROPS; OPHTHALMIC
2025/19.1.1/6821NOVARTIS SOUTH AFRICA (PTY) LTDactive31 Dec 2027
INNOLON
CAPSULE; ORAL
2017/7.3/5480INNOVATA PHARMACEUTICALS LTDactive31 Dec 2027
POL-MOXI
SOLUTION; INJECTION
2024/7.2.5/6555WMT PHARMACEUTICALSactive31 Dec 2027
XIFLOBITA
TABLET; ORAL
2024/7.3/6671MYLAN LABORATORIES LIMITEDactive31 Dec 2027
ODYCIN
SOLUTION/DROPS; OPHTHALMIC
2022/19.1.1/6249BEXIMCO PHARMACEUTICALS LTDactive31 Dec 2027
MICROMOX
SOLUTION/DROPS; OPHTHALMIC
2025/19.1.1/6819MICRO LABS LIMITEDactive31 Dec 2027

MOXIFLOXACIN HYDROCHLORIDEMCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing MOXIFLOXACIN HYDROCHLORIDE, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track MOXIFLOXACIN HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.